STOCK TITAN

27,083-Share Vesting Sale Filed by TDOC (NYSE: TDOC)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Tdoc, Inc. filed a Form 144 disclosing a proposed sale of 27,083 common shares. The securities are described as Restricted Stock Vesting with a vesting/transaction date of 02/27/2026 and are listed as issuer/compensation-related.

The filing also reports prior sales of 5,720 common shares on 12/02/2025 by Adam Vandervoort. The notice names Fidelity Brokerage Services LLC as the broker and is tied to NYSE-listed common stock.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notifies the market of a proposed sale of 27,083 vested shares tied to compensation.

The filing lists 27,083 common shares as the securities to be sold, categorized as Restricted Stock Vesting with a date of 02/27/2026. It names Fidelity Brokerage Services LLC as the executing broker and links the shares to issuer compensation.

Prior activity includes a reported sale of 5,720 shares on 12/02/2025 by Adam Vandervoort. Cash-flow treatment and intended sale timing beyond the vesting date are not specified in the excerpt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does TDOC's Form 144 report?

It reports a proposed sale of 27,083 common shares tied to restricted stock vesting. The filing lists the vesting/transaction date as 02/27/2026 and identifies Fidelity Brokerage Services LLC as the broker on NYSE-listed common stock.

Who is the selling party in the 12/02/2025 transaction?

Adam Vandervoort is reported as the seller of 5,720 common shares on 12/02/2025. That sale is disclosed separately in the filing's "Securities Sold During The Past 3 Months" section and shows the prior disposition amount.

Are the 27,083 shares part of compensation?

Yes. The filing classifies the 27,083 common shares as "Restricted Stock Vesting" and lists the issuer role as "Compensation." The vesting/transaction date shown is 02/27/2026.

Which broker is named for the proposed sale?

Fidelity Brokerage Services LLC is named as the broker for the transaction. The broker entry appears alongside the 27,083-share line and includes an address in Smithfield, RI.

Does the filing state how sale proceeds will be used?

The excerpt does not state any use-of-proceeds details. The filing identifies the shares as compensation-related and names the broker, but it does not specify proceeds recipients or uses in the provided text.
Teladoc Health Inc

NYSE:TDOC

TDOC Rankings

TDOC Latest News

TDOC Latest SEC Filings

TDOC Stock Data

915.76M
173.38M
Health Information Services
Services-offices & Clinics of Doctors of Medicine
Link
United States
NEW YORK